Premium
NICE's future without a veto on the use of expensive drugs
Author(s) -
Chaplin Steve
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.706
Subject(s) - nice , veto , medicine , interface (matter) , law and economics , risk analysis (engineering) , intensive care medicine , law , engineering , computer science , economics , politics , political science , programming language , pulmonary surfactant , gibbs isotherm , chemical engineering
Steve Chaplin describes NICE's future role after it loses the power to decide whether the use of a new drug will be cost effective. Copyright © 2011 Wiley Interface Ltd
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom